We speak with Jennifer Nuzzo, an epidemiologist at Johns Hopkins, about when the Food and Drug Administration might approve the Pfizer and BioNTech vaccine in the U.S., and whether the vaccine is safe for individuals with a history of allergic reactions.
This article was originally published on WBUR.org.
Copyright 2021 NPR. To see more, visit https://www.npr.org.